Role of transvaginal ultrasonography in diagnosing endometrial hyperplasia in pre- and post-menopause women
- PMID: 26778888
- PMCID: PMC4698852
- DOI: 10.4103/0300-1652.170390
Role of transvaginal ultrasonography in diagnosing endometrial hyperplasia in pre- and post-menopause women
Abstract
Background: Abnormal uterine bleeding (AUB) is the most common presenting symptom of endometrial hyperplasia (EH). Transvaginal ultrasonography (TVS) is a diagnostic tool in the evaluation of AUB and EH with various sensitivity and specificity. However, the exact accuracy of TVS in diagnosing EH had not been evaluated. In this study, we aim to evaluate the accuracy of TVS in detecting EH.
Materials and methods: In this retrospective study, 120 women (mean age of 48.64 ± 6.74 years) with AUB with suspicious/or possible EH were evaluated. TVS and pathology findings of possible EH were recorded. Sensitivity, specificity, positive, and negative predictive value (PPV and NPV) was calculated.
Results: Sixty-eight patients were premenopause, and 52 were postmenopause. TVS reported EH in 85 cases (70.83%). Pathology results showed EH in 85 cases (70.83%) including simple cystic hyperplasia in 82 cases, atypical, simple hyperplasia in one case and complex hyperplasia in two cases. Among these 85 cases, EH was confirmed by pathology in 81 cases. The accuracy, sensitivity, specificity, PPV, and NPV were 88.25%, 90.7%, 84%, 97.7%, and 84% in premenopause and 100% in postmenopause women.
Conclusion: TVS is an appropriate diagnostic tool in premenopause and postmenopause women presenting with AUB, especially in detecting EH. However, further studies are needed to determine the exact accuracy of TVS in diagnosing TVS.
Keywords: Abnormal uterine bleeding; endometrial hyperplasia; transvaginal ultrasonography.
Similar articles
-
TVUS coated with power Doppler in endometrial hyperplasia in pre and postmenopausal women presenting with an abnormal uterine bleeding (A Cohort Study).Clin Ter. 2025 Mar-Apr;176(2):195-200. doi: 10.7417/CT.2025.5205. Clin Ter. 2025. PMID: 40176589
-
Role of transvaginal ultrasound in identifying endometrial hyperplasia.J Ayub Med Coll Abbottabad. 2013 Jan-Jun;25(1-2):100-2. J Ayub Med Coll Abbottabad. 2013. PMID: 25098067
-
Value of endometrial thickness measurement for diagnosing focal intrauterine pathology in women without abnormal uterine bleeding.Ultrasound Obstet Gynecol. 2009 Mar;33(3):344-8. doi: 10.1002/uog.6256. Ultrasound Obstet Gynecol. 2009. PMID: 19248035
-
Imaging techniques for evaluation of the uterine cavity and endometrium in premenopausal patients before minimally invasive surgery.Obstet Gynecol Surv. 2002 Jun;57(6):388-403. doi: 10.1097/01.OGX.0000019202.67816.3F. Obstet Gynecol Surv. 2002. PMID: 12140373 Review.
-
Transvaginal ultrasound for diagnosis of adenomyosis: a review.Best Pract Res Clin Obstet Gynaecol. 2006 Aug;20(4):569-82. doi: 10.1016/j.bpobgyn.2006.01.005. Epub 2006 Mar 20. Best Pract Res Clin Obstet Gynaecol. 2006. PMID: 16545618 Review.
Cited by
-
The value of MRI in management of endometrial hyperplasia with atypia.World J Surg Oncol. 2020 Feb 10;18(1):34. doi: 10.1186/s12957-020-1811-5. World J Surg Oncol. 2020. PMID: 32041614 Free PMC article.
-
Automatic Measurement of Endometrial Thickness From Transvaginal Ultrasound Images.Front Bioeng Biotechnol. 2022 Mar 29;10:853845. doi: 10.3389/fbioe.2022.853845. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 35425763 Free PMC article.
-
Application of the International Endometrial Tumor Analysis (IETA) in Ultrasound Evaluation of Abnormal Uterine Bleeding.Cureus. 2024 Aug 10;16(8):e66560. doi: 10.7759/cureus.66560. eCollection 2024 Aug. Cureus. 2024. PMID: 39252735 Free PMC article.
-
Risk of More Advanced Lesions at Hysterectomy after Initial Diagnosis of Non-Atypical Endometrial Hyperplasia in Patients with Postmenopausal Bleeding and Oral Anticoagulant Treatment.Medicina (Kaunas). 2021 Sep 23;57(10):1003. doi: 10.3390/medicina57101003. Medicina (Kaunas). 2021. PMID: 34684040 Free PMC article.
-
The Importance of the Correlation between the Ultrasonographic Evaluation of Endometrium and Histopathological Findings in Patients with Endometrial Hyperplasia and Carcinoma.Curr Health Sci J. 2017 Apr-Jun;43(2):149-152. doi: 10.12865/CHSJ.43.02.07. Epub 2017 Jun 29. Curr Health Sci J. 2017. PMID: 30595870 Free PMC article.
References
-
- Espindola D, Kennedy KA, Fischer EG. Management of abnormal uterine bleeding and the pathology of endometrial hyperplasia. Obstet Gynecol Clin North Am. 2007;34:717–37, ix. - PubMed
-
- Marret H, Fauconnier A, Chabbert-Buffet N, Cravello L, Golfier F, Gondry J, et al. Clinical practice guidelines on menorrhagia: Management of abnormal uterine bleeding before menopause. Eur J Obstet Gynecol Reprod Biol. 2010;152:133–7. - PubMed
-
- Lacey JV, Jr, Chia VM. Endometrial hyperplasia and the risk of progression to carcinoma. Maturitas. 2009;63:39–44. - PubMed
-
- Trimble CL, Kauderer J, Zaino R, Silverberg S, Lim PC, Burke JJ, 2nd, et al. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: A gynecologic oncology group study. Cancer. 2006;106:812–9. - PubMed
-
- Eddib A, Allaf B, Lee J, Yeh J. Risk for advanced-stage endometrial cancer in surgical specimens from patients with complex endometrial hyperplasia with atypia. Gynecol Obstet Invest. 2012;73:38–42. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources